INTERNATIONAL PATENT: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS FILES APPLICATION FOR "DIACYLGLYCEROL-ACYLTRANSFERASE 1 INHIBITOR FOR USE IN A METHOD OF TREATING CANCER IN A HUMAN FEMALE PATIENT"

GENEVA, April 19 -- DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (Im Neuenheimer Feld 28069120 Heidelberg) filed a patent application (PCT/EP2024/078739) for "DIACYLGLYCEROL-ACYLTRANSFERASE 1 INHIBITOR FOR USE IN A METHOD OF TREATING CANCER IN A HUMAN FEMALE PATIENT" on Oct 11, 2024. With publication no. WO/2025/078630, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CUI, Guoliang (c/o Deutsches Krebsforschungszentrum Stiftung des offentlichen RechtsIm Neuenheimer Feld 28069120 Heidelberg), MADI, Alaa...